People's United Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,495
| Closed | -$1.84M | – | 674 |
|
|
2021
Q3 | $1.84M | Sell |
6,495
-341
| -5% | -$112K | 0.04% | 263 |
|
|
2021
Q2 | $2.37M | Buy |
6,836
+56
| +0.8% | +$17K | 0.05% | 232 |
|
|
2021
Q1 | $1.9M | Sell |
6,780
-4,840
| -42% | -$1.31M | 0.05% | 248 |
|
|
2020
Q4 | $2.85M | Buy |
11,620
+747
| +7% | +$193K | 0.07% | 183 |
|
|
2020
Q3 | $3.08M | Buy |
10,873
+5,166
| +91% | +$1.44M | 0.09% | 158 |
|
|
2020
Q2 | $1.53M | Buy |
5,707
+1,911
| +50% | +$574K | 0.04% | 237 |
|
|
2020
Q1 | $1.2M | Buy |
3,796
+3,042
| +403% | +$923K | 0.04% | 244 |
|
|
2019
Q4 | $224K | Buy |
+754
| New | +$209K | 0.01% | 681 |
|
|
2019
Q3 | – | Sell |
-951
| Closed | -$222K | – | 722 |
|
|
2019
Q2 | $222K | Sell |
951
-1,010
| -52% | -$233K | 0.01% | 704 |
|
|
2019
Q1 | $464K | Sell |
1,961
-1,566
| -44% | -$493K | 0.01% | 537 |
|
|
2018
Q4 | $1.06M | Buy |
3,527
+874
| +33% | +$279K | 0.04% | 346 |
|
|
2018
Q3 | $937K | Sell |
2,653
-310
| -10% | -$107K | 0.03% | 368 |
|
|
2018
Q2 | $860K | Buy |
2,963
+27
| +0.9% | +$7.59K | 0.02% | 470 |
|
|
2018
Q1 | $803K | Sell |
2,936
-121
| -4% | -$37.6K | 0.03% | 418 |
|
|
2017
Q4 | $974K | Buy |
+3,057
| New | +$981K | 0.03% | 380 |
|
|
2017
Q3 | – | Sell |
-2,269
| Closed | -$616K | – | 567 |
|
|
2017
Q2 | $616K | Buy |
2,269
+25
| +1% | +$6.61K | 0.02% | 453 |
|
|
2017
Q1 | $614K | Buy |
2,244
+754
| +51% | +$213K | 0.02% | 434 |
|
|
2016
Q4 | $423K | Sell |
1,490
-40
| -3% | -$11.9K | 0.02% | 481 |
|
|
2016
Q3 | $479K | Sell |
1,530
-180
| -11% | -$53.3K | 0.03% | 335 |
|
|
2016
Q2 | $414K | Sell |
1,710
-37
| -2% | -$9.75K | 0.02% | 354 |
|
|
2016
Q1 | $455K | Sell |
1,747
-70
| -4% | -$18.5K | 0.02% | 341 |
|
|
2015
Q4 | $557K | Sell |
1,817
-21,913
| -92% | -$6.3M | 0.03% | 323 |
|
|
2015
Q3 | $6.92M | Buy |
23,730
+1,887
| +9% | +$623K | 0.39% | 70 |
|
|
2015
Q2 | $8.82M | Buy |
21,843
+4,364
| +25% | +$1.75M | 0.46% | 60 |
|
|
2015
Q1 | $7.38M | Buy |
17,479
+206
| +1% | +$81.2K | 0.37% | 72 |
|
|
2014
Q4 | $5.86M | Sell |
17,273
-983
| -5% | -$318K | 0.3% | 80 |
|
|
2014
Q3 | $6.04M | Buy |
18,256
+308
| +2% | +$102K | 0.32% | 79 |
|
|
2014
Q2 | $5.66M | Buy |
17,948
+1,386
| +8% | +$417K | 0.3% | 82 |
|
|
2014
Q1 | $5.07M | Buy |
16,562
+227
| +1% | +$72.1K | 0.3% | 78 |
|
|
2013
Q4 | $4.57M | Buy |
16,335
+2,776
| +20% | +$718K | 0.26% | 84 |
|
|
2013
Q3 | $3.26M | Buy |
13,559
+10,336
| +321% | +$2.31M | 0.21% | 89 |
|
|
2013
Q2 | $694K | Buy |
+3,223
| New | +$689K | 0.05% | 224 |
|
Other funds holding BIIB
People's United Financial's BIIB Position: Q4 2021 in Review
People's United Financial sold out of Biogen (BIIB) in Q4 2021, closing a stake of 6,495 shares — an estimated $1.84M sold.
People's United Financial first reported a position in BIIB in Q2 2013 and held it in 32 quarters. The position peaked at $8.82M in Q2 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- People's United Financial reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
- People's United Financial sold 6,495 Biogen shares in Q4 2021, an estimated $1.84M.
- People's United Financial first reported a position in Biogen in Q2 2013 and held it in 32 quarters.
- People's United Financial's Biogen position peaked at $8.82M in Q2 2015.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on People's United Financial's 13F filing for Q4 2021, filed 14 Feb 2022.